1. Harries MJ, Sinclair RD, MacDonald-Hull S, Whiting DA, Griffiths CEM, Paus R. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol. 2008;159(1):1–22.
2. PROPECIA® (finasteride) tablets for oral use [Internet]. Drugs@FDA: FDA Approved Drug Products. 2014 [cited 2018 Mar 21]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020788.
3. Drugs@FDA: FDA Approved Drug Products. Women’s Rogaine 5% Minoxidil Topical Aerosol, Approval History and Label [Internet]. [cited 2018 Mar 29]. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist.
4. McMichael AJ, Pearce DJ, Wasserman D, Camacho FT, Fleischer AB, Feldman SR, et al. Alopecia in the United States: outpatient utilization and common prescribing patterns. J Am Acad Dermatol. 2007;57(2 Suppl):S49–51.
5. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med. 1993;66(6):541–54.